Showing 78,961 - 78,980 results of 123,983 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((mean decrease) OR (point decrease)) ))', query time: 1.84s Refine Results
  1. 78961

    Placental Cadmium Levels Are Associated with Increased Preeclampsia Risk by Jessica E. Laine (801664)

    Published 2015
    “…There was an increased odds ratio for PE in relationship to placental levels of Cd (OR = 1.5; 95% CI: 1.1–2.2). The Cd-associated OR for PE increased when analyzed in relationship to lower placental Se levels (OR = 2.0; 95% CI: 1.1–3.5) and decreased with higher placental Se levels (OR = 0.98; 95% CI: 0.5–1.9). …”
  2. 78962

    Impact of optimal 1/week/6 m allopregnanolone treatment regimen on neurogenesis and survival in 3xTgAD male mouse. by Shuhua Chen (11649)

    Published 2013
    “…CldU positive cells were not significantly increased in both ages suggesting that this APα treatment regimen sustained survival of newly generated cells, and that neurogenic capacity of APα decreased with age. The percentage increase was presented as mean ± SEM; * <i>P</i><0.01; <i>n</i> = 2–5/group.…”
  3. 78963

    Effects of human VEGF165 and HGF on IL-8 and MCP-1 production by endothelial cells <i>in vitro</i>. by Pavel I. Makarevich (5249657)

    Published 2018
    “…B—Autoradiograms of membrane stained for pIκBα и IκBα after Western blotting of extracts from HUVEC stimulated by VEGF165 (25 ng/ml), HGF (25 ng/ml) or VEGF165+HGF (25 ng/ml total); HSA (25 ng/ml) served as a negative, and TNF-α (5 ng/ml) as a positive control. …”
  4. 78964

    Time- and dose-dependent effects of cytostatic drug treatment on B16 cell proliferation. by Kathrin Pfarr (700517)

    Published 2015
    “…<p>The decreasing intensity of the CFSE dye as a degree for the proliferation rate of the cells is shown (mean ± SD, n = 3). …”
  5. 78965

    Supplementary Material for: Significant Dry Weight Reduction After Transition from Peritoneal Dialysis to Hemodialysis by Lin Y.-T. (17065287)

    Published 2025
    “…After transitioning to HD, body weight decreased significantly, with a reduction of -2.8 kg at one month, -5.3 kg at three months, and -7.5 kg one year post-transition. …”
  6. 78966

    Conceptual schema of phenotypic plasticity in salamander larvae in the presence of dragonfly larvae. by Tadashi Iwami (35758)

    Published 2013
    “…Enlargement of the external gills can be reached by two pathways, a multi-step pathway via the antipredator behaviour (decreased surfacing) and the consequent hypoxia, and a direct pathway via predator-produced cues.…”
  7. 78967

    Data_Sheet_1_Trajectories of (Bio)markers During the Development of Cognitive Frailty in the Doetinchem Cohort Study.pdf by M. Liset Rietman (6760496)

    Published 2019
    “…</p><p>Methods: The Doetinchem Cohort Study is a longitudinal population-based study that started in 1987–1991 in men and women aged 20–59 years, with follow-up examinations every 5 years. …”
  8. 78968

    Data_Sheet_2_Trajectories of (Bio)markers During the Development of Cognitive Frailty in the Doetinchem Cohort Study.pdf by M. Liset Rietman (6760496)

    Published 2019
    “…</p><p>Methods: The Doetinchem Cohort Study is a longitudinal population-based study that started in 1987–1991 in men and women aged 20–59 years, with follow-up examinations every 5 years. …”
  9. 78969

    Table_4_The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blood of Multibacillary Leprosy Patients With Erythema Nodosum Leprosum.DOCX by Thabatta Leal Silveira Andrezo Rosa (5489132)

    Published 2022
    “…During thalidomide administration, the drug of choice for ENL treatment, a decrease in the mRNA and protein levels of some of these genes both in the skin and blood was observed. …”
  10. 78970

    The p53<sup>R172H</sup> Mutant Does Not Enhance Hepatocellular Carcinoma Development and Progression by Leanne G. Ahronian (725754)

    Published 2015
    “…Since the frequency of p53 mutation increases with tumor grade in HCC, we hypothesized that p53<sup>R172H</sup> is a gain-of-function mutation in HCC that contributes to a decrease in tumor-free survival and an increase in metastasis. …”
  11. 78971

    Table_3_The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blood of Multibacillary Leprosy Patients With Erythema Nodosum Leprosum.DOCX by Thabatta Leal Silveira Andrezo Rosa (5489132)

    Published 2022
    “…During thalidomide administration, the drug of choice for ENL treatment, a decrease in the mRNA and protein levels of some of these genes both in the skin and blood was observed. …”
  12. 78972

    Image_1_The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blood of Multibacillary Leprosy Patients With Erythema Nodosum Leprosum.TIF by Thabatta Leal Silveira Andrezo Rosa (5489132)

    Published 2022
    “…During thalidomide administration, the drug of choice for ENL treatment, a decrease in the mRNA and protein levels of some of these genes both in the skin and blood was observed. …”
  13. 78973

    Table_1_Novel therapeutic approach to slow down the inflammatory cascade in acute/subacute spinal cord injury: Early immune therapy with lipopolysaccharide enhanced neuroprotective... by Shiva Hashemizadeh (782629)

    Published 2022
    “…For this purpose, we determined the optimum injection time and sub-toxic dosage of LPS following a T10 contusion injury. Medium-dose LPS administration may result in a local anti-inflammatory beneficial role. …”
  14. 78974

    Image_2_The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blood of Multibacillary Leprosy Patients With Erythema Nodosum Leprosum.TIF by Thabatta Leal Silveira Andrezo Rosa (5489132)

    Published 2022
    “…During thalidomide administration, the drug of choice for ENL treatment, a decrease in the mRNA and protein levels of some of these genes both in the skin and blood was observed. …”
  15. 78975

    Table_6_The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blood of Multibacillary Leprosy Patients With Erythema Nodosum Leprosum.DOCX by Thabatta Leal Silveira Andrezo Rosa (5489132)

    Published 2022
    “…During thalidomide administration, the drug of choice for ENL treatment, a decrease in the mRNA and protein levels of some of these genes both in the skin and blood was observed. …”
  16. 78976

    Table_7_The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blood of Multibacillary Leprosy Patients With Erythema Nodosum Leprosum.DOCX by Thabatta Leal Silveira Andrezo Rosa (5489132)

    Published 2022
    “…During thalidomide administration, the drug of choice for ENL treatment, a decrease in the mRNA and protein levels of some of these genes both in the skin and blood was observed. …”
  17. 78977

    Table_1_The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blood of Multibacillary Leprosy Patients With Erythema Nodosum Leprosum.DOCX by Thabatta Leal Silveira Andrezo Rosa (5489132)

    Published 2022
    “…During thalidomide administration, the drug of choice for ENL treatment, a decrease in the mRNA and protein levels of some of these genes both in the skin and blood was observed. …”
  18. 78978

    Table_2_The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blood of Multibacillary Leprosy Patients With Erythema Nodosum Leprosum.DOCX by Thabatta Leal Silveira Andrezo Rosa (5489132)

    Published 2022
    “…During thalidomide administration, the drug of choice for ENL treatment, a decrease in the mRNA and protein levels of some of these genes both in the skin and blood was observed. …”
  19. 78979

    MG-132 enhanced apoptosis induction and caspase-8 cleavage due to DX1 treatment in HL-60 cells. by Zhiying Yu (356965)

    Published 2013
    “…</b> HL-60 cells were treated with DMSO (control), MG-132 0.5 µM, DX1 8 µM or MG132 plus DX1 for 10 h. The percentage of apoptotic cells was determined by morphological observation after AO/EB staining as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0015843#s2" target="_blank">Materials and Methods</a>. * <i>P</i><0.05 and ** <i>P</i><0.01 compared to cells treated without MG132. …”
  20. 78980

    Impact of alternative assumptions on life expectancy. by Chara E. Rydzak (242195)

    Published 2010
    “…Depending on the baseline CD4 cell count, life-expectancy was increased by 14.8 to 30.9 months with no late failure (green), and was decreased by 2.8 to 6.6 months with 1.5-fold increase in late failure (orange), and by 5.1 to 11.0 months with a 2-fold increase in late failure (red). …”